A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Scopoline Butylbromide - Request Quote

Picture of Scopoline Butylbromide

Scopoline Butylbromide

SZ CAT No:SZ-H013022
CAS No
NA
Mol.F.
C12H22NO2 : Br
Mol.Wt.
212.3 : 79.9
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Scopoline Butylbromide is chemically 4-Butyl-6-hydroxy-4-methylhexahydro-2H-2,5-methanofuro[3,2-b]pyrrol-4-ium bromide. Scopoline Butylbromide is supplied with detailed characterization data compliant with regulatory guideline. Scopoline Butylbromide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Hyoscine Butylbromide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Scopoline Butylbromide

Purchase Scopoline Butylbromide

Scopoline Butylbromide suppliers

Scopoline Butylbromide manufacturers

Scopoline Butylbromide price

Order Scopoline Butylbromide

Enquire Scopoline Butylbromide

Scopoline Butylbromide cost

Scopoline Butylbromide Supplier

Scopoline Butylbromide Distributor

Scopoline Butylbromide for Method Validation

Hyoscine Butylbromide Reference Standard

Scopoline Butylbromide for ANDA Filing

Scopoline Butylbromide for Forced Degradation Studies

Scopoline Butylbromide Identification Standards

Scopoline Butylbromide for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,